🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Massachusetts

Pag-aaral pangklinika para sa Diffuse Intrinsic Pontine Glioma sa Massachusetts

9 pag-aaral para sa Diffuse Intrinsic Pontine Glioma ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Susan Chi, Boston
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

  • Dana-Farber Cancer Institute Harvard University, Boston
Nagre-recruitPhase 2
Edad 2 hanggang 39 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitMaagang Phase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
Nagre-recruitPhase 1
12 Months – 18 Years · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT04943848

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.